MPTs: Articles
from the Field

Issue #30 - 17 October 2016


Dear Colleagues,


The Multipurpose Prevention Technologies (MPTs) field is steadily evolving and expanding. Provided below are links to recent publications, media articles, and other resources relevant to MPTs to keep you up-to-date. Please note that contents are neither endorsed by nor necessarily represent the views of the Initiative for Multipurpose Prevention Technologies (IMPT), and that due to publication copyright and permissions restrictions, full-text versions of resources may not be publicly available.


If you have a resource to include in our next issue, please send to Vanetta Thomas at Previous issues are available on the IMPT website.     




IMPT Secretariat Staff


If you will be attending the 2016 APHA annual meeting check out our presentation  STIs and the Increasing Epidemiological Need for Innovative Sexual Reproductive Health Prevention: The Promise of Multipurpose Prevention Technologies, which is scheduled to be presented on Tuesday, November 1, 2016 at 8:30 am during session 4070.0, "When I get that feeling, I need...: Investigating barriers to women's sexual and reproductive health."

Journal Articles

An Exploratory Study of Acculturation and Reproductive Health Among Haitian and Haitian-American Women in Little Haiti, South Florida. Cyrus, E., Gollub, EL., Jean-Gilles, M., Neptune, S., Pelletier, V., Dévieux, J. (2016, June). Journal for Immigrant and Minority Health, 18(3), 666-72.
  Multipurpose Tenofovir Disoproxil Fumarate Electrospun Fibers for the Prevention of HIV-1 and HSV-2 Infections. (Masters Thesis) . Tyo, K. (2016, August). University of Louisville. ThinkIR: The University of Lousiville's Institutional Repository.
MZC gel inhibits SHIV-RT and HSV-2 in macaque vaginal mucosa and SHIV-RT in rectal Mucosa . Calenda, G., Barnable, P., Litterst, C., Levendosky, K., Gettie, A., Cooney, M., ...& Teleshove, N. (2016). Journal of Acquired Immune Deficiency Syndromes. (Publish Ahead of Print). DOI: 10.1097/QAI.0000000000001167.
"This Method, I Think, Can Shed New Light": Haitian-American Women's Reflections on Risk, Culture, and Family Planning Decisions From a Short-Term Trial of a Cervical Barrier (Femcap™) . Gollub, EL., Dévieux, J., Michele, JG.,  Pierre Ste-Rose, S., Neptune, S., Pelletier, V. (2016, September). International Quarterly of Community Health Education, 0(0), 1-11.

Qualitative Analysis of Sexually Experienced Female Adolescents: Attitudes about Vaginal Health . Francis, JK., Fraiz, LD., Catallozzi, M., Rosenthal, SL. (2016, October). Journal of Pediatric and Adolescent Gynecology, 29(5), 496-500.

Media Articles

HIVR4P Ushers in "Next-Gen" Prevention . Boerner, H. (2016, October 12). MedScape.

'Female' Condoms Cost Too Much: A Call for HIV Prevention Equality for Receptive Sex Partners . Terlikowski, J. & Forbes, A. (2016, April 12). The Body. 

The Enduring Unpopularity of the Female Condom. Ro, C. (2016, June 6).The Atlantic. 

Zimbabwe: HIV Prevention as Treatment. Sachiti, R. (2016, October 11). All Africa. 


2015 IPM Annual Report: New Hope for Women's HIV Prevention . (2016, September). International Partnership for Microbicides (IPM). 

Funding Opportunities 

RFA-HD-17-013 - The Purpose section of the FOA is to support and facilitate multidisciplinary approaches to the development of new and/or improved contraceptive methods for both men and women. This FOA expands the scope of the former program by calling for Centers to inform contraceptive development and improve contraceptive use by integrating the biomedical research and development with behavioral and social science research, e.g., demography and other population sciences, psychology, economics, and sociology.
Please note that the receipt date is January 18, 2017.

Career Opportunities 

USAID - Medical Officer, Microbicide Branch of the Research Division, Office of HIV/AIDS. The Medical Officer will support clinical testing, development, and implementation of HIV prevention technologies, especially microbicides and PrEP in the near term, as well as alternative ARV-based products, vaccines, and other novel approaches in the future.  Responsibilities will include a significant role in managing the current portfolio of microbicide projects as well as developing new initiatives in this program area, in collaboration with other Research Division and USAID staff.  This position may contribute to relevant activities in the Vaccine Branch and Implementation Science Branch as well.  A range of both technical and management skills will be useful in this role.  For additional information, please see . Note that applicants must be US citizens and this posting closes October 18, 2016.

USAID - Health Science Specialist, HIV Vaccine Branch, Office of HIV/AIDS.
The Health Science Specialist will serve as a Biomedical Research Specialist and technical expert for USAID-assisted HIV and AIDS research efforts in the planning, design, development and implementation of new technologies and their applications in international HIV and AIDS programming. For additional information, please see . This posting closes October 21, 2016.
Visit and
for more resources on MPTs.

Facebook    Twitter

IMPT Secretariat

308 Natoma Street, Suite 150
Folsom, CA 95630